834TiPA randomized controlled, open label, adaptive phase...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

834TiPA randomized controlled, open label, adaptive phase III Trial to evaluate safety and efficacy of endoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment

Chen, L-T, Hitre, E, Lee, W-J, Bai, L-Y, Papaï, Z, KANG, S Y, Dvorkin, M, Choi, H J, Oh, S C, Artru, P, Bachet, J-B
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.160
Date:
October, 2019
File:
PDF, 81 KB
2019
Conversion to is in progress
Conversion to is failed